After a wait of 6 yrs, whistleblower gets Rs 13L DRI reward

Employee who informed intelligence agency about customs duty evasion by own company says the long wait for reward discourages whistleblowers Ihad left my job, had no other means of employment and was running short on savings in the three years after I turned whistleblower for the Directorate of Revenue Intelligence (DRI). Unfortunately, I got the… Continue reading After a wait of 6 yrs, whistleblower gets Rs 13L DRI reward

Why coronavirus virus could hit Indian pharma industry

Written by Prabha Raghavan | New Delhi | Updated: January 31, 2020 9:48:08 am India is vulnerable also because it is heavily dependent on China for components used to make products across industries, including essential medicines.Now that a case of infection by the novel coronavirus (2019-nCoV) has been flagged in India, central and state governments… Continue reading Why coronavirus virus could hit Indian pharma industry

Aurobindo Pharma unit VII gets OAI from USFDA

However, the company said it will work closely with the drug regulator to comprehensively address the issues. (Representative image)Aurobindo Pharma has said that the drug regulator US Food and Drug Administration (USFDA) has cautioned that its oral solids formulation manufacturing facility in Telangana may be subject to regulatory actions.However, the company said it will work closely… Continue reading Aurobindo Pharma unit VII gets OAI from USFDA

Strides Pharma posts threefold rise in profit-before-tax at Rs 103.6 crore

The Bengaluru-headquartered company posted a 358 per cent rise in net profit at 101 crore as compared to the corresponding quarter of the previous financial year Pharmaceutical major Strides Pharma Science posted a threefold rise in profit-before-tax (PBT) at Rs 103.6 crore for the third quarter ended December 31. It had posted a pre-tax profit… Continue reading Strides Pharma posts threefold rise in profit-before-tax at Rs 103.6 crore

Coronavirus outbreak: China shutdown to hit Indian drug manufacturers

Coronavirus outbreak is likely to disrupt supplies of drug ingredients for Indian pharma manufacturers, mostly antibiotics and vitamin makersIndian drug manufacturers are to a large extent dependent on China for sourcing their drug ingredients or the active pharmaceutical ingredients, as the industry words it. This is largely for drugs like antibiotics – crucial among them… Continue reading Coronavirus outbreak: China shutdown to hit Indian drug manufacturers

Coronavirus pandemic threatens to cut pharmaceutical industry’s lifeline

NEW DELHI: China’s coronavirus pandemic is threatening to disrupt India’s $39-billion drug production by halting or severely affecting the flow of imports of bulk drugs and intermediates from the country. India, the world’s third-largest drug producer by volume, imports 70% of its raw materials from the Middle Kingdom. This may slow down to a trickle,… Continue reading Coronavirus pandemic threatens to cut pharmaceutical industry’s lifeline

India’s production of paracetamol, top antibiotics could be hit by China coronavirus crisis

Children wearing facial masks, as a precaution after Nepal confirmed the first case of coronavirus in the country, attend a lecture at Matribhumi School in Thimi, Bhaktapur, Nepal on Wednesday | ANI/Reuters Text Size: New Delhi: The supply of raw materials to produce top-selling antibiotics, anti-diabetic medicines and commonly used paracetamol could be hit in… Continue reading India’s production of paracetamol, top antibiotics could be hit by China coronavirus crisis

Budget 2020 : Healthcare industry expects infrastructure push, tax incentives for R&D

by Rashmi MabiyanNEW DELHI: Amidst a slowing economy, healthcare experts expect the Union Budget 2020 to provide a breather to the healthcare and pharma industry which has been reeling under challenges for quite a while now. Robust infrastructure, access to diagnostics, comprehensive healthcare policy, tax incentives are some of the expectations of the healthcare industry… Continue reading Budget 2020 : Healthcare industry expects infrastructure push, tax incentives for R&D

Health-Records Company Pushed Opioids to Doctors in Secret Deal With Drugmaker

Bloomberg the Company & Its ProductsThe QuintBloomberg Bloomberg | Quint is a multiplatform, Indian business and financial news company. We combine Bloomberg’s global leadership in business and financial news and data, with Quintillion Media’s deep expertise in the Indian market and digital news delivery, to provide high quality business news, insights and trends for India’s… Continue reading Health-Records Company Pushed Opioids to Doctors in Secret Deal With Drugmaker

US offers $30 billion more market to domestic pharma companies

Despite being the largest export market for domestic pharma makers, they served only a miniscule 5.6 per cent or $6.5 billion of the over $116 billion American pharma imports of in 2018, show the WTC data.The WTC has identified 10 products that constitute about 25% of American pharma imports in 2018 at $ 29.6 billion… Continue reading US offers $30 billion more market to domestic pharma companies